Depotech(depo) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo)

DEPO 7.300

+1.7%

Aug 14 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: biao luo who wrote (568)	12/18/1997 11:03:00 PM
From: Miljenko Zuanic	Read Replies (2) of 887

To all: In my early posts I was concern about drop-off numbers and side effects of the DepoCyt. Today news show (at least according to press) that side-effects are main problem. Regards the efficiency, company did not give wrong data, but they did put positive spin on data! Thanks Biao, you explained well. How litle math can do a big swing. Anyway my understanding was that DepoCyt do not need to show better efficiency if side effects are reduced. Data on chemical arachnoiditis was unknown for majority investors. Suddenly this side effects (~65%) are main problem for FDA and it appears that they did surprise DEPO to. If drop-off is because patients died during study (and dead is not related to drug) than DepoCyt is significantly efficient. Otherwise there are no benefit because survival time for both drug become near equal. My condolence to all DEPO long. Including myself. For dogs and hyenas, who recently join thread with hype without knowing company and technology, my message is: this time you got it! mz

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next